Belle Mead, NJ, United States of America

Richard Scott Pottorf

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Richard Scott Pottorf

Introduction

Richard Scott Pottorf is an accomplished inventor based in Belle Mead, NJ (US). He holds three patents, showcasing his contributions to the field of pharmaceutical sciences. His work primarily focuses on arginase inhibitors, which have significant implications for treating various medical conditions.

Latest Patents

Pottorf's latest patents include innovative compounds aimed at inhibiting arginase activity. One of his notable inventions is directed to arginase inhibitor compounds of specific formulas, along with their pharmaceutically acceptable salts. These compounds are designed for the treatment and diagnosis of conditions characterized by upregulation of arginase or abnormally high arginase activity. Another patent involves methods of treating or diagnosing conditions associated with high arginase activity or low nitric oxide levels in mammals, emphasizing the therapeutic potential of his discoveries.

Career Highlights

Throughout his career, Pottorf has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Corridor Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Pottorf has collaborated with notable professionals in his field, including Bruce Edward Tomczuk and Gary Olson. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Richard Scott Pottorf's work in developing arginase inhibitors represents a significant advancement in medical science. His patents reflect his dedication to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…